BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29084478)

  • 21. Moving low value care lists into action: prioritizing candidate health technologies for reassessment using administrative data.
    Soril LJJ; Seixas BV; Mitton C; Bryan S; Clement FM
    BMC Health Serv Res; 2018 Aug; 18(1):640. PubMed ID: 30111308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring policy-makers' perspectives on disinvestment from ineffective healthcare practices.
    Elshaug AG; Hiller JE; Moss JR
    Int J Technol Assess Health Care; 2008; 24(1):1-9. PubMed ID: 18218163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.
    Henry DA; Hill SR; Harris A
    JAMA; 2005 Nov; 294(20):2630-2. PubMed ID: 16304078
    [No Abstract]   [Full Text] [Related]  

  • 24. The application of economics concepts to stratified medicine--use of health economics data to support market access for stratified medicine interventions.
    Fugel HJ; Nuijten M; Faulkner E
    J Med Econ; 2014 May; 17(5):305-11. PubMed ID: 24654841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disinvestment from low value clinical interventions: NICEly done?
    Garner S; Littlejohns P
    BMJ; 2011 Jul; 343():d4519. PubMed ID: 21795239
    [No Abstract]   [Full Text] [Related]  

  • 27. Creating value-focused healthcare delivery systems: Part three--Core competencies.
    Beveridge RN
    J Oncol Manag; 1997; 6(6):16-23. PubMed ID: 10174597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mental health economics: insights from Brazil.
    Cruz L; Lima AF; Graeff-Martins A; Maia CR; Ziegelmann P; Miguel S; Fleck M; Polanczyk C
    J Ment Health; 2013 Apr; 22(2):111-21. PubMed ID: 23574503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development, implementation and evaluation of an evidence-based program for introduction of new health technologies and clinical practices in a local healthcare setting.
    Harris C; Garrubba M; Allen K; King R; Kelly C; Thiagarajan M; Castleman B; Ramsey W; Farjou D
    BMC Health Serv Res; 2015 Dec; 15():575. PubMed ID: 26707549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.
    Morton A; Adler AI; Bell D; Briggs A; Brouwer W; Claxton K; Craig N; Fischer A; McGregor P; van Baal P
    Health Econ; 2016 Aug; 25(8):933-8. PubMed ID: 27374115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The iterative use of economic evaluation as part of the process of health technology assessment.
    Sculpher M; Drummond M; Buxton M
    J Health Serv Res Policy; 1997 Jan; 2(1):26-30. PubMed ID: 10180650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.
    Garrison LP; Towse A; Briggs A; de Pouvourville G; Grueger J; Mohr PE; Severens JL; Siviero P; Sleeper M
    Value Health; 2013; 16(5):703-19. PubMed ID: 23947963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies.
    Gazelle GS; McMahon PM; Siebert U; Beinfeld MT
    Radiology; 2005 May; 235(2):361-70. PubMed ID: 15858079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres.
    Smith JBE; Channon KM; Kiparoglou V; Forbes JF; Gray AM
    PLoS One; 2019; 14(4):e0214361. PubMed ID: 30970015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of investment for enterprise application integration technology in healthcare organisations: a cost-benefit approach.
    Khoumbati K; Shah SG; Dwivedi YK; Shah MH
    Int J Electron Healthc; 2007; 3(4):453-67. PubMed ID: 18048277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In healthcare, more or less, less is more: notes on healthcare disinvestment].
    Peiró S
    Rev Esp Sanid Penit; 2014; 16(3):68-74. PubMed ID: 25418826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technology assessment for the anesthesiologist.
    Abenstein JP
    Anesthesiol Clin; 2006 Dec; 24(4):677-96. PubMed ID: 17342958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health technology assessment: history and demand.
    Stevens A; Milne R; Burls A
    J Public Health Med; 2003 Jun; 25(2):98-101. PubMed ID: 12848396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.